自体富血小板纤维蛋白（PRF）治疗宫腔粘连专家共识

doi:10.3969/j.issn.1671-2587.2022.03.002

临床输血与检验 ›› 2022, Vol. 24 ›› Issue (3): 279-284.DOI: 10.3969/j.issn.1671-2587.2022.03.002

自体富血小板纤维蛋白（PRF）治疗宫腔粘连专家共识

中国人体健康科技促进会妇科内分泌和生育力促进分会, 中国女医师协会输血专业委员会

收稿日期:2022-05-16 出版日期:2022-06-20 发布日期:2022-06-22
通讯作者: 白文佩,女,主任医师、教授,博士研究生导师,主要从事妇科内分泌,妇科微创治疗研究,（E-mail）baiwp@bjsjth.cn。马海梅,女,主任技师,主要研究方向为患者血液管理、血型血清学、血栓止血学,（E-mail）mhm69@126.com。
作者简介:陈麟凤（首都医科大学附属北京世纪坛医院）、杨慕坤（首都医科大学附属北京世纪坛医院）

Received:2022-05-16 Online:2022-06-20 Published:2022-06-22

摘要/Abstract

摘要： 富血小板纤维蛋白（platelet rich fibrin ,PRF）作为一种外科生物添加剂,通过抽取患者自体非抗凝全血制备。近二十年以来,PRF以其制备过程简单,高效修复受损组织等特点被广泛用于各种医学领域。随着PRF在组织修复领域的广泛应用,研究者开始探索将PRF应用于宫腔粘连（intrauterine adhesion,IUA）的治疗中。本专家共识由中国人体健康科技促进会妇科内分泌和生育力促进分会和中国女医师协会输血专业委员会牵头组织,由来自全国的在宫腔粘连治疗领域有着丰富经验的妇产科专家和具有PRF 制备经验的输血医学专家共同编写,本共识基于专家经验和现有医学证据,为医护人员在治疗IUA的临床实践中规范化地应用PRF提供指导意见。

关键词: 富血小板纤维蛋白, 宫腔粘连, 规范化应用, 专家共识

中图分类号:

R457
R711

中国人体健康科技促进会妇科内分泌和生育力促进分会, 中国女医师协会输血专业委员会. 自体富血小板纤维蛋白（PRF）治疗宫腔粘连专家共识[J]. 临床输血与检验, 2022, 24(3): 279-284.

参考文献

[1] HEINONEN PK.Intrauterine adhesions--Asherman's syndrome[J].Duodecim;Laaketieteellinen Aikakauskirja, 2010,126(21):2486-2491.
[2] DREISLER E,KJER J J.Asherman's syndrome:current perspectives on diagnosis and management[J].Int J Womens Health,2019,11:191-198.
[3] CAPMAS P,MIHALACHE A,DUMINIL L,et al.Intrauterine adhesions:what is the pregnancy rate after hysteroscopic management?[J]. J Gynecol Obstet Hum Reprod,2020,49(7):101797.
[4] LEE W L,LIU C H,CHENG M,et al.Focus on the primary prevention of intrauterine adhesions:current concept and vision[J]. Int J Mol Sci,2021,22(10):5175.
[5] KOU L F,JIANG X,XIAO S Y,et al.Therapeutic options and drug delivery strategies for the prevention of intrauterine adhesions[J].J Control Release,2020,318:25-37.
[6] ZHENG F,XIN X,HE F,et al.Meta-analysis of the use of hyaluronic acid gel to prevent intrauterine adhesions after miscarriage[J]. Eur J Obstet Gynecol Reprod Biol,2020,244:1-4.
[7] PENG J T,LI M Z,ZENG H T,et al.Intrauterine infusion of platelet-rich plasma is a treatment method for patients with intrauterine adhesions after hysteroscopy[J].Int J Gynaecol Obstet,2020,151(3):362-365.
[8] JAVAHERI A,KIANFAR K,POURMASUMI S,et al.Platelet-rich plasma in the management of Asherman's syndrome:an RCT[J]. Int J Reprod Biomed,2020,18(2):113-120.
[9] ALBAZEE E,AL-RSHOUD F,ALMAHMOUD L,et al.Platelet-rich plasma for the management of intrauterine adhesions:a systematic review and meta-analysis of randomized controlled trials[J]. J Gynecol Obstet Hum Reprod,2022,51(2):102276.
[10] PUENTE GONZALO E,ALONSO PACHECO L,VEGA JIMÉNEZ A,et al. Intrauterine infusion of platelet-rich plasma for severe Asherman syndrome:a cutting-edge approach[J]. Updates Surg,2021,73(6):2355-2362.
[11] CHENG Y H,TSAI N C,CHEN Y J,et al.Extracorporeal shock wave therapy combined with platelet-rich plasma during preventive and therapeutic stages of intrauterine adhesion in a rat model[J]. Biomedicines,2022,10(2):476.
[12] CHOUKROUN J,ADDA F,SCHOEFFLER C,et al.Une opportunit? ? en Paro-implantologie:le PRF[J]. Implantodontie,2001,42:55-62.
[13] Alrayyes Y,Al-Jasser R. Regenerative potential of platelet rich fibrin (PRF) in socket preservation in comparison with conventional treatment modalities:a systematic review and meta-analysis[J]. Tissue Eng Regen Med,2022:2022 Mar 25.
[14] DOHAN D M,CHOUKROUN J,DISS A,et al.Platelet-rich fibrin (PRF):a second-generation platelet concentrate. Part II:platelet-related biologic features[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology,2006,101(3):e45-e50.
[15] DOHAN D M,CHOUKROUN J,DISS A,et al.Platelet-rich fibrin (PRF):a second-generation platelet concentrate. Part Ⅲ:leucocyte activation:a new feature for platelet concentrates?[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2006,101(3):e51-e55.
[16] LOURENÇO E S,MOURÃO C,LEITE P E C,et al. The in vitro release of cytokines and growth factors from fibrin membranes produced through horizontal centrifugation[J]. J Biomed Mater Res A,2018,106(5):1373-1380.
[17] GOLEBIEWSKA E M,POOLE A W.Platelet secretion:from haemostasis to wound healing and beyond[J]. Blood Rev,2015,29(3):153-162.
[18] ROY S,DRIGGS J,ELGHARABLY H,et al.Platelet-rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation[J].Wound Repair Regen,2011,19(6):753-766.
[19] ZEITOUNLOUIAN T S,ZENO K G,BRAD B A,et al.Three-dimensional evaluation of the effects of injectable platelet rich fibrin (i-PRF) on alveolar bone and root length during orthodontic treatment:a randomized split mouth trial[J].BMC Oral Health,2021,21(1):92.
[20] YÜCE E,KÖMERIK N.Potential effects of advanced platelet rich fibrin as a wound-healing accelerator in the management of alveolar osteitis:a randomized clinical trial[J]. Niger J Clin Pract,2019,22(9):1189-1195.
[21] ÖZCAN E,SAYGUN I,KANTARCı A,et al.The effects of a novel non-invasive application of platelet-rich fibrin on periodontal clinical parameters and gingival crevicular fluid transforming growth factor-β and collagen-1 levels:a randomized,controlled,clinical study[J]. J Periodontol,2021,92(9):1252-1261.
[22] KARAKASLI K,ERDUR E A.The effect of platelet-rich fibrin (PRF) on maxillary incisor retraction rate[J]. Angle Orthod,2021,91(2):213-219.
[23] OZSAGIR Z B,SAGLAM E,SEN YILMAZ B,et al.Injectable platelet-rich fibrin and microneedling for gingival augmentation in thin periodontal phenotype:a randomized controlled clinical trial[J].J Clin Periodontol,2020,47(4):489-499.
[24] SHAH R,M G T,THOMAS R,et al.An update on the protocols and biologic actions of platelet rich fibrin in dentistry[J].Eur J Prosthodont Restor Dent,2017,25(2):64-72.
[25] PICCIN A,DI PIERRO A M,CANZIAN L,et al. Platelet gel:a new therapeutic tool with great potential[J]. Blood Transfus,2017,15(4):333-340.
[26] DORJAY K,SINHA S.Platelet-rich fibrin in nonhealing leg ulcers:a simple and effective therapeutic option[J]. J Cutan Aesthet Surg,2021,14(2):160-165.
[27] SHAO S Y,PAN R P,CHEN Y.Autologous platelet-rich plasma for diabetic foot ulcer[J].Trends Endocrinol Metab,2020,31(12):885-890.
[28] KARTIKA R W,ALWI I,SUYATNA F D,et al.Wound healing in diabetic foot ulcer patients using combined use of platelet rich fibrin and hyaluronic acid,platelet rich fibrin and placebo:an open label,randomized controlled trial[J].Acta Med Indones,2021,53(3):268-275.
[29] YU P X,ZHAI Z,JIN X L,et al.Clinical application of platelet-rich fibrin in plastic and reconstructive surgery:a systematic review[J].Aesthetic Plast Surg,2018,42(2):511-519.
[30] REKSODIPUTRO M H,HUTAURUK S M,WIDODO D W,et al.Platelet-rich fibrin enhances surgical wound healing in total laryngectomy[J]. Facial Plast Surg,2021,37(3):325-332.
[31] GRECU A F,RECLARU L,ARDELEAN L C,et al.Platelet-rich fibrin and its emerging therapeutic benefits for musculoskeletal injury treatment[J]. Medicina (Kaunas),2019,55(5):141.
[32] HABESOGLU M,OYSU C,SAHIN S,et al.Platelet-rich fibrin plays a role on healing of acute-traumatic ear drum perforation[J].J Craniofac Surg,2014,25(6):2056-2058.
[33] WANG Y C,CHEN X,MAO L L,et al.Therapeutic effect of platelet-rich fibrin transplant on formation of thin endometrium[J]. Exp Clin Transplant,2021,19(6):600-608.
[34] WANG Z J,YANG M K,MAO L L,et al.Efficacy and safety of autologous platelet-rich fibrin for the treatment of infertility with intrauterine adhesions[J]. J Obstet Gynaecol Res,2021,47(11):3883-3894.
[35] BLAIR P,FLAUMENHAFT R.Platelet α-granules:basic biology and clinical correlates[J]. Blood Rev,2009,23(4):177-189.
[36] 杨慕坤, 王子君, 崔广霞, 等.富血小板纤维蛋白对宫腔粘连创面修复的影响研究[J].临床输血与检验,2022,24(3):363-368.
[37] BAYER A,LAMMEL J,RADEMACHER F,et al.Platelet-released growth factors induce the antimicrobial peptide human beta-defensin-2 in primary keratinocytes[J]. Exp Dermatol,2016,25(6):460-465.
[38] DOHAN EHRENFEST D M,DEL CORSO M,DISS A,et al.Three-dimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane[J]. J Periodontol,2010,81(4):546-555.
[39] 中华医学会妇产科学分会.宫腔粘连临床诊疗中国专家共识[J].中华妇产科杂志,2015,50(12):881-887.
[40] 美国卫生及公共服务部.美国常见不良反应术语评定标准(CTCAE)5.0版[S].2017.

自体富血小板纤维蛋白（PRF）治疗宫腔粘连专家共识

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 7

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	中国输血协会人类组织抗原专业委员会, 中国输血协会免疫血液学专业委员会. 免疫性血小板输注无效的判定及临床实践专家共识^*[J]. 临床输血与检验, 2022, 24(3): 273-278.
[2]	林放, 周谋, 李文丹, 孙宇, 骆美良, 单桂秋. 富血小板纤维蛋白对金黄色葡萄球菌-大肠杆菌混合菌的体外抑菌效果研究^*[J]. 临床输血与检验, 2022, 24(3): 320-324.
[3]	杨慕坤, 王子君, 崔广霞, 陈麟凤, 白文佩. 富血小板纤维蛋白对宫腔粘连创面修复的影响研究^*[J]. 临床输血与检验, 2022, 24(3): 363-368.
[4]	北京医学会输血医学分会, 北京医师协会输血专业专家委员会. 中国输血医师规范化培训实施方案专家共识[J]. 临床输血与检验, 2021, 23(1): 1-5.
[5]	中国输血协会免疫血液学专业委员会. 胎儿新生儿溶血病实验室检测专家共识^*[J]. 临床输血与检验, 2021, 23(1): 20-24.
[6]	中国医师协会输血科医师分会. 医疗机构中乙型肝炎病毒、丙型肝炎病毒、人类免疫缺陷病毒(1+2型)核酸检测策略专家共识[J]. 临床输血与检验, 2020, 22(6): 561-564.
[7]	魏亚明, 桂嵘, 王秋实, 刘志伟. 血小板抗体检测专家共识[J]. 临床输血与检验, 2020, 22(1): 1-5.